Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07626424
CompletedNCT07626424ClinicalTrials.gov record

Local Vibration for Drooling in Children With Cerebral Palsy

Cerebral Palsy (CP)

THE QUICK READ

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type
Interventional
Phase
Not applicable
Age range
2 years - 18 years
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
23 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

This randomized-controlled trial evaluates local vibration therapy for drooling and orofacial muscle biomechanics in children with cerebral palsy. Participants receive either local vibration plus conventional physiotherapy or sham vibration plus conventional physiotherapy.

Read the full description

This randomized-controlled trial aims to evaluate the effects of local vibration therapy on drooling severity and perioral and submandibular muscle biomechanics in children with cerebral palsy. Participants will be allocated to either an experimental group receiving local vibration in addition to conventional physiotherapy or a control group receiving sham vibration with conventional physiotherapy. Local vibration will be applied to the perioral and submandibular regions for 5 minutes each over three consecutive days. Assessments will be conducted at baseline, immediately after the third intervention session, and at 1-week follow-up.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Diagnosis of cerebral palsy
  • Age between 2 and 18 years
  • Presence of anterior drooling
  • Drooling severity and frequency score ≥ 3 on a standardized drooling scale

Exclusion Criteria:

  • History of surgical intervention for drooling management
  • History of botulinum toxin injection for drooling management
  • Use of medications affecting salivary control
  • Presence of progressive neurological disease
  • Presence of salivary gland pathology or active upper respiratory tract infection
  • History or symptoms of aspiration pneumonia within the last 6 months
  • Indication for surgical treatment of drooling (e.g., more than four clothing changes per day and presence of chin or neck dermatitis)
  • Uncontrolled seizures
  • Presence of oral or perioral lesions
  • Presence of gastrostomy tube
  • Treatment adherence below 85%
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Random assignment
Masking
Double masked
Local Vibration Group

In this group, participants will receive conventional physiotherapy combined with local vibration therapy. Local vibration will be applied to the perioral and submandibular regions for 5 minutes each (total 10 minutes per session) once daily for three consecutive days using a vibration device.

Other: Local Vibration Therapy

Sham Vibration Group

In this group, participants will receive conventional physiotherapy combined with sham vibration. The vibration device will be activated but not applied to the skin surface. The procedure will mimic the experimental protocol in duration and setting and will be performed once daily for three consecutive days.

Other: Sham Vibration

Local Vibration Therapy OTHER

Local vibration therapy will be applied to the perioral and submandibular regions using a vibration device for 5 minutes each (total 10 minutes per session), once daily for three consecutive days.

Sham Vibration OTHER

Sham vibration will be administered using the same device without contact with the skin. The intervention will be delivered for 10 minutes per session, once daily for three consecutive days.

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Muscle Tone

Time frame: Baseline, immediately after the third intervention session, and 1-week follow-up

Muscle tone of the perioral and submandibular muscles (orbicularis oris and anterior digastric muscles) will be evaluated using a portable hand-held myotonometer (MyotonPRO). The MyotonPRO applies a short mechanical impulse to the skin overlying the muscle or fascia. The tissue response generates a signal that is recorded, and the internal software produces an acceleration graph.

Muscle Stiffness

Time frame: Baseline, immediately after the third intervention session, and 1-week follow-up

Muscle stiffness of the perioral and submandibular muscles (orbicularis oris and anterior digastric muscles) will be evaluated using a portable hand-held myotonometer (MyotonPRO). The MyotonPRO applies a short mechanical impulse to the skin overlying the muscle or fascia. The tissue response generates a signal that is recorded, and the internal software produces an acceleration graph.

Muscle Elasticity (logarithmic decrement)

Time frame: Baseline, immediately after the third intervention session, and 1-week follow-up

Muscle elasticity of the perioral and submandibular muscles (orbicularis oris and anterior digastric muscles) will be evaluated using a portable hand-held myotonometer (MyotonPRO). The MyotonPRO applies a short mechanical impulse to the skin overlying the muscle or fascia. The tissue response generates a signal that is recorded, and the internal software produces an acceleration graph.

Secondary measures

Change in drooling severity and frequency

Time frame: Baseline, immediately after the third intervention session, and 1-week follow-up

Drooling severity and frequency will be assessed using a standardized drooling scale, with severity scored from 1 (no drooling) to 5 (severe drooling) and frequency scored from 1 (no drooling) to 4 (constant drooling)

Global Rating of Change Scale

Time frame: Immediately after the third intervention session and 1-week follow-up

Parent-reported global rating of change using the Global Rating of Change Scale. Scores range from -7 (very much worse) to +7 (very much improved), with higher scores indicating greater perceived improvement.

Caregiver-reported drooling burden

Time frame: Baseline, immediately after the third intervention session, and 1-week follow-up

Caregivers will report the frequency of clothing changes and use of tissues related to drooling.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Atlas Özel Eğitim ve Rehabilitasyon MerkeziVan, Turkey (Türkiye)Status unknown

Study team and timeline

Lead sponsor
Bitlis Eren University
Study start
Jun 15, 2026 Actual
Primary completion
Nov 5, 2026 Actual
Study completion
Nov 5, 2026 Actual
First posted
Jun 4, 2026 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Effects of Local Vibration on Orofacial Muscle Tone and Drooling in Children With Cerebral Palsy

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026